Wells Fargo & Company »

Neuropace shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $834 81 10.31
2023-09-30 $719 74 9.73
2023-06-30 $1.0k 223 4.49
2022-12-31 $101 68 1.49
2022-09-30 $0 86 0.00
2022-06-30 $0 43 0.00
2022-03-31 $13k 1.6k 8.15
2021-12-31 $41k 4.1k 10.07
2021-09-30 $161k 10k 15.82
2021-06-30 $243k 10k 23.77